---
abstract: 'Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of six HCC prediction models for UK patients with cirrhosis and a hepatitis C virus (HCV) virological cure.'
authors: ["Hamish Innes", "Peter Jepsen", "Scott McDonald", "John Dillon", "Victoria Hamill", "admin", "Jennifer Benselin", "April Went", "Andrew Fraser", "Andrew Bathgate", "M. Azim Ansari", "Stephen Barclay", "David Goldberg", "Peter Hayes", "Philip Johnson", "Eleanor Barnes", "William Irving", "Sharon Hutchinson", "Indra Neil Guha"]
date: "2021-10-07"
doi: "10.1016/j.jhepr.2021.100384"
featured: false
image:
  caption: ''
  focal_point: ""
projects: []
publication: '*JHEP Reports*'
publication_short: ""
publication_types:
- "2"
slides:
summary: We conducted an external validation of six HCC prediction models for UK patients with cirrhosis HCV virological cure.
tags:
- HCV
- DAA
- PWID
- Reinfection
title: 'Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured hepatitis C infection'
url_code: ""
url_dataset: ""
url_pdf: ""
url_poster: ""
url_project: ""
url_slides: ""
url_source: ""
url_video: ""
---
